||Dihydrothymine is an intermediate breakdown product of thymine.
||7-Methylxanthine, a methyl derivative of xanthine, is one of the purine components in urinary calculi.
||Adenosine is a ribonucleoside comprised of adenine bound to ribose, with vasodilatory, antiarrhythmic and analgesic activities.
||Cytidine is a pyrimidine nucleoside comprised of a cytosine bound to ribose via a beta-N1-glycosidic bond. Cytidine is a precursor for uridine. Both cytidine and uridine are utiliz
||Tipiralacil is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
||7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8 ± 7.5 µM).
||3-Methylcytidine as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer.
||N2-methylguanosine is a modified nucleoside of tRNA that occurs at several specific locations in many tRNA's
||6-O-Methyl Guanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line.
||6-Thioinosine (6TI) is a purine antimetabolite, acts as an anti-adipogenesis agent.
||Ethynylcytidine is a nucleoside antimetabolite.
||Sapacitabine is a nucleoside analog prodrug with antitumor activity.
||Triazavirin is a nucleoside analogue of nucleic acid and an antiviral agent.